Stem Point Capital LP Legend Biotech Corp Transaction History
Stem Point Capital LP
- $312 Billion
- Q2 2025
A detailed history of Stem Point Capital LP transactions in Legend Biotech Corp stock. As of the latest transaction made, Stem Point Capital LP holds 270,144 shares of LEGN stock, worth $9.99 Million. This represents 3.08% of its overall portfolio holdings.
Number of Shares
270,144Holding current value
$9.99 Million% of portfolio
3.08%Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
238Shares Held
60MCall Options Held
591KPut Options Held
381K-
Westfield Capital Management CO LP Boston, MA6.92MShares$256 Million1.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$221 Million8.76% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$212 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.77MShares$140 Million4.61% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$110 Million2.42% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.19B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...